Presentation is loading. Please wait.

Presentation is loading. Please wait.

Addressing Cardiovascular Events:

Similar presentations


Presentation on theme: "Addressing Cardiovascular Events:"— Presentation transcript:

1 Addressing Cardiovascular Events:

2

3 Educational Objectives

4 A multicenter, double-blind, randomized study to establish the clinical benefit and safety of ezetimibe/simvastatin tablet (vytorin) vs simvastatin monotherapy in high-risk patients presenting with acute coronary syndrome

5 Biologic Basis For Lowering LDL-C

6 LDL Hypothesis Is Lowering the LDL Enough, Or Does the Agent Matter?

7 Determinants of Atherosclerosis

8

9 Study Design

10 IMPROVE-IT Study Goals

11 IMPROVE-IT Not a Placebo Study

12

13 IMPROVE-IT Ezetimibe/Simvastatin Reduces Risk of Cardiovascular Events

14 IMPROVE-IT Safety Data

15 Safety of Other LDL Lowering Treatments

16 Abstract Presented at ACC 2015

17 Hypothesis

18 Number of Primary End Point Events

19 Total Primary End Point Events

20 What we know about “Lower is Better”

21 Conclusions

22 Conclusions

23 Abbreviations

24 Abbreviations (cont)

25 References

26 References (cont)

27 References (cont)


Download ppt "Addressing Cardiovascular Events:"

Similar presentations


Ads by Google